HPN |
HPN, TMPRSS1: Serine protease hepsin |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
27.980 |
Evidence |
|
HPN |
HPN, TMPRSS1: Serine protease hepsin |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
27.980 |
Evidence |
|
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
27.980 |
Evidence |
|
NCF4 |
NCF4, SH3PXD4: Neutrophil cytosol factor 4 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
27.950 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
27.950 |
Evidence |
|
SPARC |
SPARC, ON: SPARC precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
27.950 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
IRS2 |
IRS2: Insulin receptor substrate 2 |
27.950 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
27.950 |
Evidence |
|
SNCG |
SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein |
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
27.950 |
Evidence |
|
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
27.950 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
27.950 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
27.950 |
Evidence |
|
CRKL |
CRKL: Crk-like protein |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
27.950 |
Evidence |
O
|
S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
27.950 |
Evidence |
|
LTA |
LTA, TNFB, TNFSF1: Lymphotoxin-alpha precursor |
TNF |
TNF, TNFA, TNFSF2: Tumor necrosis factor precursor |
27.950 |
Evidence |
O
|
DOK1 |
DOK1: Docking protein 1 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
27.950 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
27.950 |
Evidence |
|
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
27.950 |
Evidence |
|
MECP2 |
MECP2: Methyl-CpG-binding protein 2 |
CSTF2T |
CSTF2T, KIAA0689: Cleavage stimulation factor 64 kDa subunit, tau variant |
27.950 |
Evidence |
|
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
SYK |
SYK: Tyrosine-protein kinase SYK |
27.950 |
Evidence |
|
C2 |
C2: Complement C2 precursor |
CFH |
CFH, HF, HF1, HF2: Complement factor H precursor |
27.950 |
Evidence |
|
IRS2 |
IRS2: Insulin receptor substrate 2 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
27.950 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
VASP |
VASP: Vasodilator-stimulated phosphoprotein |
27.950 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
27.950 |
Evidence |
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
27.950 |
Evidence |
|